COMMUNITY STRATEGIC INITIATIVES

Community Strategic Initiatives seek to enable people and communities to improve the quality of life of people living with and those most at risk of HIV.

To achieve this, our Community Strategic Initiatives funding is provided in the form of:

Innovator Funding

Up to £100,000 over two years (£50,000 per year)

  • Investments into the testing and piloting of new approaches
  • The proposed approach(es) must be new to the funding applicant but can have been delivered by another organisation in a different location or aimed at a different target population
  • A two 2-year pilot that aims to build evidence before scale-up

Momentum Funding

Up to £300,000 over three years (£ 100,000 per year)

  • Advancing existing, evidence-based projects to enable sustainable scale-up
  • The funding applicant must have delivered the approach(es) previously and have evidence that the approach(es) work
  • Funding can be used to build on previous investments made by Positive Action or other donors
  • A three-year scale-up aimed at advancing previous projects with a focus on sustaining interventions beyond the three year Positive Action investment

Please see here for current and upcoming funding rounds.

Medium shot of kids holding hands

OTHER POSITIVE ACTION STRATEGY FUNDING INITIATIVES

The Paediatric Breakthrough partners, working with government and community, aim to locate, link, treat and retain mothers and children at risk or living with HIV.

Reference:

  1. UNAIDS Global AIDS Update 2022 Full report — In Danger: UNAIDS Global AIDS Update 2022 

NP-GBL-HVX-COCO-220002 | February 2024

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.